Condition: Short Stature Children Born Small for Gestational Age (SGA) · Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
This study will take place at multiple sites and is divided into three phases:an initial 4-week getting-to-know-you phase,a 26-week main phase where participants receive medication,and a 4-week follow-up phase.Participants will be divided into three groups:two will receive different doses of PEG-rhGH Injection,and the third will receive hGH Injection.The goal is to determine which medication works best.
This description comes directly from the study's public registry record.
Xiao Ping Luo · +8613387522645 · xpluo888@sina.com
Ling Hou · +8613437131846 · houlingtj@163.com
Always discuss trial participation with your own doctor first.
| Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07260500